Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Intralesional Triamcinolone Acetonide in Vitiligo: A Prospective, Double-Blind Randomized Controlled Trial

NCT01766609 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT01766609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01766609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Intralesional Triamcinolone Acetonide in Vitiligo: A Prospective, Double-Blind Randomized Controlled Trial
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2013
Completion date
January 31, 2016
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo